OpenVSafe by OpenVAERS
Search V-safe

3RH-13229-57462

4 vaccinations 12 coded responses 42 check-ins 11 free-text entries 4 call cases
Sex
Female
Age at first dose
21-25
ZIP prefix
201 / VA
Registered
2021-01-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-19
    Registered in v-safe
  2. 2021-01-19
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-19
    Survey response — day 0, dose 1
    MedDRA: Dizziness — Feeling: Good · Fever · Fatigue or tiredness
    Free text: a little dizziness after the shot
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · None
    Adult check-in
  5. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-26
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-02
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-09
    Dose 2 — Pfizer-BioNTech
  11. 2021-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  12. 2021-02-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  13. 2021-02-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Oropharyngeal pain — Feeling: Fair · Headache, Nausea
    Free text: slight sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness, Nausea
    Adult check-in
  15. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Abdominal pain
    Adult check-in
  16. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Muscle or body aches
    Adult check-in
  17. 2021-02-16
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-23
    Survey response — day 14, dose 2
    MedDRA: Dyspepsia, Throat tightness — Feeling: Good
    Free text: Increased heartburn, and throat constriction (like asthma or allergies)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-09
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-16
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  22. 2021-03-25
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-11
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-08-10
    Survey response — 6 months, dose 2
    MedDRA: Acne, Dermatitis contact, Ear discomfort, Hospitalisation, Rash, Rash pruritic, Sepsis, Skin infection — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Sepsis of the face requiring hospitalization (infected acne)Itchy bumps all over my body (suspected sensitivity to new laundry detergent)Blocked left ear canal
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  25. 2021-08-10
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-08-17
  27. 2021-10-03
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  28. 2021-10-03
    Health check-in — day 0, dose 3
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  29. 2021-10-04
    Survey response — days 1–6 daily, dose 3
    MedDRA: Sensitive skin — Feeling: Poor · Site: Pain, Swelling · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Free text: Skin sensitivity to temperature
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  31. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  32. 2021-10-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-10-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  34. 2021-10-12
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-10-19
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-10-26
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-10-31
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-07
    Survey response — day 35, dose 3
    MedDRA: Nasal congestion, Nasal vestibulitis, Rhinalgia, Tenderness — Feeling: Good
    Free text: Nasal vestibulitis, pain, tenderness, and swelling in the inside of my right nostril
    MedDRA releases: 2024-11 · check-in free text available
  39. 2021-11-14
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-01-02
    Survey response — 3 months, dose 3
    MedDRA: Dyspnoea, Exposure to SARS-CoV-2 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Shortness of breath for over a week with 3 negative PCR tests within that time. Exposure to COVID 2 days before onset of symptoms.
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-01-02
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  42. 2022-01-03
  43. 2022-04-03
    Survey response — 6 months, dose 3
    MedDRA: Anxiety, Dyspnoea, Nasopharyngitis, Ovarian cyst — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Common cold Ovarian cysts trouble breathing from anxiety
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-04-03
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  45. 2022-04-05
  46. 2022-09-12
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  47. 2022-10-03
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: COVID, sinus infection
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-10-03
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  49. 2022-10-05
  50. 2022-10-05
  51. 2022-10-05
  52. 2022-10-05
  53. 2022-10-07
    Survey response — day 21, dose 4
    MedDRA: Dyspnoea, Pre-existing disease — Feeling: Good
    Free text: Some trouble breathing, probably just long covid
    MedDRA releases: 2024-11 · check-in free text available
  54. 2022-10-12
    Survey response — day 28, dose 4
    MedDRA: Pre-existing disease, Sneezing — Feeling: Good
    Free text: sneezing from mold allergies
    MedDRA releases: 2024-11 · check-in free text available
  55. 2022-10-19
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  56. 2022-10-24
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  57. 2022-12-12
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  58. 2023-03-13
    Survey response — 6 months, dose 4
    MedDRA: Nasal congestion, Nasopharyngitis, Oropharyngeal pain — Feeling: Good
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-01-19Pfizer-BioNTech
22021-02-09Pfizer-BioNTech
32021-10-03Pfizer-BioNTech Flu
42022-09-12Pfizer-BioNTech Flu

Call center

4 call center cases

4 unsuccessful

See the call center timeline

Free text

Release 2 — day 0, dose 1

2021-01-19

Systemic reaction (other): a little dizziness after the shot

Release 4 — days 1–6 daily, dose 2

2021-02-12

Systemic reaction (other): slight sore throat

Release 4 — day 14, dose 2

2021-02-23

Symptoms: Increased heartburn, and throat constriction (like asthma or allergies)

Release 9 — 6 months, dose 2

2021-08-10

Symptoms: Sepsis of the face requiring hospitalization (infected acne)Itchy bumps all over my body (suspected sensitivity to new laundry detergent)Blocked left ear canal

Release 10 — days 1–6 daily, dose 3

2021-10-04

Systemic reaction (other): Skin sensitivity to temperature

Release 10 — day 35, dose 3

2021-11-07

Symptoms: Nasal vestibulitis, pain, tenderness, and swelling in the inside of my right nostril

Release 10 — 3 months, dose 3

2022-01-02

Symptoms: Shortness of breath for over a week with 3 negative PCR tests within that time. Exposure to COVID 2 days before onset of symptoms.

Release 11 — 6 months, dose 3

2022-04-03

Symptoms: Common cold Ovarian cysts trouble breathing from anxiety

Release 12 — 12 months, dose 3

2022-10-03

Symptoms: COVID, sinus infection

Release 12 — day 21, dose 4

2022-10-07

Symptoms: Some trouble breathing, probably just long covid

Release 12 — day 28, dose 4

2022-10-12

Symptoms: sneezing from mold allergies

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAcne ✓ · ✓
SDAnxiety · · ✓
SDCOVID-19 · · ✓
SDDermatitis contact ✓ · ✓
SDDyspepsia ✓ ✓ ✓
SDDyspnoea · · ✓
SDEar discomfort ✓ · ✓
SDExposure to SARS-CoV-2 · · ✓
SDHospitalisation ✓ · ✓
SDNasal congestion · · ✓
SDNasal vestibulitis · · ✓
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDOvarian cyst · · ✓
SDPre-existing disease · · ✓
SDRash ✓ · ✓
SDRash pruritic ✓ · ✓
SDRhinalgia · · ✓
SDSARS-CoV-2 test negative · · ○
SDSepsis ✓ · ✓
SDSinusitis · · ✓
SDSkin infection ✓ · ✓
SDSneezing · · ✓
SDTenderness · · ✓
SDThroat tightness ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓
SROSensitive skin · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release